RISPERIDONE DEPOT vs ARIPIPRAZOLE
Adverse events: Specific ‐ prolactin‐related · patients with schizophrenia
It is very uncertain whether RISPERIDONE DEPOT changes adverse events: Specific ‐ prolactin‐related compared with ORAL ARIPIPRAZOLE (very low certainty).
1 finding from 1 review
- RR 9.91 [2.78, 35.29]2 studies · 729 participantsVery low